gene_id TARGET USI Entity ID Gender Age at Diagnosis in Days Age group(18 months) Event Free Survival Time in Days Event First Event Vital Status Overall Survival Time in Days Vital status INSS Stage MYCN status MYCN Amplified Histology Histology Grade MKI MKI Diagnostic Category COG Risk Group High Risk Percent Tumor v/s Stroma 00e47068-3dcc-4b3d-ba10-8371a1d33cbc TARGET-30-PARYNK TARGET-30-PARYNK-01A-01R 2 2279 2 2351 0 Censored Alive 2351 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 90/10 0a01a5ee-1df4-405e-8eb6-98fa0a480ace TARGET-30-PALEVG TARGET-30-PALEVG-01A-01R 1 666 2 4948 0 Censored Alive 4948 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 0a57b5c6-4a57-49b0-b20c-6252d39f002a TARGET-30-PATHVK TARGET-30-PATHVK-01A-01R 2 2109 2 171 1 Progression Alive 1807 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 90/10 0fc262f2-9c2e-4f28-af3f-337fccc68465 TARGET-30-PAPKXS TARGET-30-PAPKXS-01A-01R 2 2547 2 978 1 Relapse Dead 2384 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 01c87dd9-4a5d-4cdd-844d-749394deda96 TARGET-30-PASXRJ TARGET-30-PASXRJ-01A-01R 2 583 2 266 1 Progression Alive 1837 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 60/40 1a20922e-1093-4cbc-b466-a89c2f0e8487 TARGET-30-PASNML TARGET-30-PASNML-01A-01R 1 8 1 2185 0 Censored Alive 2185 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma Low Risk 0 0 1c60f740-95aa-4287-8329-96ec8f871ab2 TARGET-30-PATDXG TARGET-30-PATDXG-01A-01R 1 688 2 2052 0 Censored Alive 2052 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 90/10 1eb90879-2cb0-4cc2-ae58-eefacd1715d0 TARGET-30-PARZIP TARGET-30-PARZIP-01A-01R 1 2273 2 632 1 Relapse Alive 2511 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 80/20 02a86e96-346e-4ffa-bada-23b1823416b6 TARGET-30-PATDXC TARGET-30-PATDXC-01A-01R 1 1659 2 444 1 Event Dead 916 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 80/20 2f2ca307-4a07-4dfe-9c97-d07fc84b5e37 TARGET-30-PASCFC TARGET-30-PASCFC-01A-01R 1 18 1 2522 0 Censored Alive 2522 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Low Risk 0 0 2fe4059e-31ea-4500-ab59-6e0219d5158b TARGET-30-PAPTFZ TARGET-30-PAPTFZ-01A-01R 1 564 2 516 1 Relapse Dead 779 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 5/95 3a318128-af26-4e70-a5b5-06ae5be107f3 TARGET-30-PAMZGT TARGET-30-PAMZGT-01A-01R 1 602 2 603 1 Relapse Alive 3823 0 4 Amplified 1 Unknown NA Unknown Unknown NA Neuroblastoma High Risk 1 0 3bd0d901-5f08-48c3-91b6-27acd103e6b6 TARGET-30-PAPVXS TARGET-30-PAPVXS-01A-01R 1 1366 2 224 1 Death Dead 224 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 80/20 3f7b7f18-4219-40d6-b721-d73aa934f6f7 TARGET-30-PARZCJ TARGET-30-PARZCJ-01A-01R 1 242 1 2435 0 Censored Alive 2435 0 3 Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Intermediate Risk 0 70/30 4a4870d5-d6ef-4edc-ada0-6183752b8b14 TARGET-30-PASFIC TARGET-30-PASFIC-01A-01R 1 51 1 2152 0 Censored Alive 2152 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Low Risk 0 0 4a946572-ad2c-4759-baf4-0a8cbe3ed5df TARGET-30-PAMYCE TARGET-30-PAMYCE-01A-01R 2 1059 2 392 1 Relapse Dead 995 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 4aae239e-9b2e-4a89-af99-ae4f3cbe1fff TARGET-30-PARSBI TARGET-30-PARSBI-01A-01R 2 2390 2 1377 1 Relapse Dead 1743 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 90/10 4e4df7f7-121f-4237-9611-ad11e64ac1de TARGET-30-PALKUC TARGET-30-PALKUC-01A-01R 2 823 2 4399 0 Censored Alive 4399 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 0 4f13947f-1cf8-44d6-bdb6-13f9668dbcfd TARGET-30-PASXHE TARGET-30-PASXHE-01A-01R 1 1438 2 2098 0 Censored Alive 2098 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 80/20 5f27bcfe-5da2-4d45-ae08-1dd7612610e9 TARGET-30-PAPTDH TARGET-30-PAPTDH-01A-01R 2 11 1 193 1 Second Malignant Neoplasm Alive 3264 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Low Risk 0 40/60 5f98aeeb-518c-4546-a252-ba7049de61bf TARGET-30-PATFXV TARGET-30-PATFXV-01A-01R 2 648 2 236 1 Progression Dead 296 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 70/30 6ad1f4f9-dec0-4ded-8391-45efeb7ffe8d TARGET-30-PASMNT TARGET-30-PASMNT-01A-01R 2 4802 2 233 1 Progression Dead 1696 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 85/15 6ae8bc40-ca9f-4b71-a809-4d70396b116a TARGET-30-PANBJH TARGET-30-PANBJH-01A-01R 2 1030 2 168 1 Progression Dead 920 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 6d783035-7375-4d76-8f27-415a1e42d37e TARGET-30-PASVRU TARGET-30-PASVRU-01A-01R 1 631 2 254 1 Event Dead 440 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 80/20 6ea52dc5-77be-4a8d-8234-97d7800b44b3 TARGET-30-PALIIN TARGET-30-PALIIN-01A-01R 1 1279 2 684 1 Relapse Dead 1395 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 90/10 7b6e55b7-ffed-4d53-baee-55f791069424 TARGET-30-PASTCN TARGET-30-PASTCN-01A-01R 1 1900 2 870 1 Relapse Dead 1033 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 50/50 7b36fef1-f02b-4294-b1b8-559808bbdbb6 TARGET-30-PALWVJ TARGET-30-PALWVJ-01A-01R 1 1544 2 417 1 Relapse Dead 803 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 90/10 7c1a8c9e-0e38-4344-b79e-73aceb75489a TARGET-30-PASHFA TARGET-30-PASHFA-01A-01R 2 406 1 201 1 Progression Dead 333 1 3 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 60/40 7c2b0108-1231-4543-a8bf-eb6644e76f41 TARGET-30-PAIXIF TARGET-30-PAIXIF-01A-01R 1 1315 2 2228 0 Censored Alive 2228 0 4 Not Amplified 0 Unfavorable 1 Unknown Intermediate 2 "Ganglioneuroblastoma, nodular" High Risk 1 0 7cccad17-8596-4032-9433-e293f2044d79 TARGET-30-PARBAJ TARGET-30-PARBAJ-01A-01R 1 35 1 302 1 Relapse Alive 3122 0 3 Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma Intermediate Risk 0 0 7cee37af-64ff-4983-bfbf-cb4f95d2b796 TARGET-30-PALNVP TARGET-30-PALNVP-01A-01R 2 1155 2 4665 0 Censored Alive 4665 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 0 7e145f1d-1807-4615-95b5-2684ccbcb348 TARGET-30-PAISNS TARGET-30-PAISNS-01A-01R 1 1070 2 410 1 Event Dead 421 1 4 Not Amplified 0 Unknown NA Unknown Unknown NA Unknown High Risk 1 0 7e182ed6-c8aa-4185-a6f5-d351a98b7608 TARGET-30-PAPEFE TARGET-30-PAPEFE-01A-01R 1 990 2 138 1 Progression Dead 150 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 8bd4f593-7cab-42f0-b604-044442bb661e TARGET-30-PATGJU TARGET-30-PATGJU-01A-01R 2 59 1 1219 0 Censored Alive 1219 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Low Risk 0 0 8c78ab0d-7e08-4518-94d3-dca147c8bb97 TARGET-30-PANZPV TARGET-30-PANZPV-01A-01R 2 1757 2 1013 1 Relapse Dead 1261 1 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA Neuroblastoma High Risk 1 0 8e24367d-a474-4be9-be51-b951ba1af051 TARGET-30-PASCTR TARGET-30-PASCTR-01A-01R 1 60 1 2325 0 Censored Alive 2325 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Intermediate Risk 0 0 8ec5dd32-aab9-4c78-a5c2-dc9e0d55af65 TARGET-30-PATINJ TARGET-30-PATINJ-01A-01R 1 1037 2 736 1 Relapse Dead 822 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 75/25 8ed55a74-56b7-486a-86cb-87aecd0a84bf TARGET-30-PASEGA TARGET-30-PASEGA-01A-01R 1 1091 2 469 1 Progression Dead 809 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 "Ganglioneuroblastoma, nodular" High Risk 1 70/30 8f70446e-c591-4ac1-bacb-64f78acf056f TARGET-30-PASRFS TARGET-30-PASRFS-01A-01R 2 1328 2 1675 1 Relapse Alive 2075 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 70/30 8f97235c-f3b2-4757-b3c8-24701e5348c7 TARGET-30-PALZZV TARGET-30-PALZZV-01A-01R 2 699 2 1494 1 Event Alive 1934 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 90/10 8fe7274c-9053-40a1-8b2d-7e125195a28d TARGET-30-PASSRS TARGET-30-PASSRS-01A-01R 1 2492 2 861 1 Relapse Dead 1319 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 65/35 9b93ed0a-1316-4dd4-bfd8-b6807927a7ad TARGET-30-PARACM TARGET-30-PARACM-01A-01R 2 1442 2 2994 0 Censored Alive 2994 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 "Ganglioneuroblastoma, nodular" High Risk 1 10-20/80-90 9d0e0be5-16a6-4898-bb6b-08113ca10cde TARGET-30-PASZKE TARGET-30-PASZKE-01A-01R 1 31 1 8 1 Death Dead 8 1 4s Not Amplified 0 Unknown NA Undifferentiated or Poorly Differentiated High 3 Neuroblastoma Intermediate Risk 0 0 9df25fe5-9aa3-4097-ad77-dd0139716b59 TARGET-30-PAPEAV TARGET-30-PAPEAV-01A-01R 2 696 2 3462 0 Censored Alive 3462 0 4 Not Amplified 0 Unfavorable 1 Differentiating Low 1 Neuroblastoma High Risk 1 0 9fd943be-b3d4-4fc1-8f22-69edf84f1871 TARGET-30-PASZPI TARGET-30-PASZPI-01A-01R 1 645 2 453 1 Progression Dead 1014 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 40/60 13cdd61f-3aae-46cc-beae-af27862ab950 TARGET-30-PATBMM TARGET-30-PATBMM-01A-01R 1 1112 2 709 1 Relapse Alive 768 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 90/10 17ff18b9-9c97-45d4-9b8f-63f00f9afe6b TARGET-30-PASJZC TARGET-30-PASJZC-01A-01R 2 74 1 367 1 Relapse Alive 2083 0 4s Amplified 1 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 0 20cfdbe0-d8be-4a00-aab9-d3011912a8dc TARGET-30-PATHKB TARGET-30-PATHKB-01A-01R 1 7 1 1998 0 Censored Alive 1998 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Intermediate Risk 0 0 25f23554-b21d-4967-8b7b-040a200b5651 TARGET-30-PANRVJ TARGET-30-PANRVJ-01A-01R 1 4781 2 3722 0 Censored Alive 3722 0 4 Not Amplified 0 Unfavorable 1 Differentiating Intermediate 2 Neuroblastoma High Risk 1 0 26c392ed-b4ff-49d5-a2c2-8979a7563b96 TARGET-30-PASGUT TARGET-30-PASGUT-01A-01R 1 1259 2 401 0 Censored Alive 401 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 90/10 43aeaf6a-3f84-41d2-9cd7-a6ead15aa241 TARGET-30-PAPZYP TARGET-30-PAPZYP-01A-01R 2 1010 2 2386 0 Censored Alive 2386 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Unknown NA Neuroblastoma High Risk 1 90/10 58fb41e7-6659-4483-96ab-28c086f21d9f TARGET-30-PASTKC TARGET-30-PASTKC-01A-01R 1 3035 2 1952 0 Censored Alive 1952 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 30-40/60-70 61b147dc-a769-42be-86c1-57b6ecf119ac TARGET-30-PASXGP TARGET-30-PASXGP-01A-01R 1 834 2 1898 0 Censored Alive 1898 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 20/80 66c76b87-e10c-4f76-80f3-cb274e1b795b TARGET-30-PASUML TARGET-30-PASUML-01A-01R 1 4 1 12 1 Event Dead 20 1 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Intermediate Risk 0 0 78ff9515-5ac4-49f0-ad4c-ec169e644b9f TARGET-30-PAPBGH TARGET-30-PAPBGH-01A-01R 2 1074 2 470 1 Relapse Dead 723 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Unknown NA Neuroblastoma High Risk 1 0 84b1ca2e-4732-426a-bbac-9720579ee30e TARGET-30-PARFRE TARGET-30-PARFRE-01A-01R 2 60 1 2451 0 Censored Alive 2451 0 4s Not Amplified 0 Favorable 0 Unknown Unknown NA Neuroblastoma Low Risk 0 0 84f91861-c750-4bed-94b3-834a91018aba TARGET-30-PANXJL TARGET-30-PANXJL-01A-01R 1 5734 2 431 0 Censored Alive 431 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 0 87c94a89-6345-4079-9e0d-17a91d6a96ed TARGET-30-PALTEG TARGET-30-PALTEG-01A-01R 1 1367 2 523 1 Relapse Dead 551 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 92fd610e-05fa-48ea-8127-42def9574406 TARGET-30-PATFCY TARGET-30-PATFCY-01A-01R 1 1040 2 787 1 Death Dead 787 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 90/10 95b94a40-d6dc-4dba-9f35-f7b0e983bd40 TARGET-30-PANWRR TARGET-30-PANWRR-01A-01R 1 2937 2 267 1 Progression Dead 345 1 4 Not Amplified 0 Unfavorable 1 Differentiating Low 1 Neuroblastoma High Risk 1 0 204a726c-7058-4580-8131-37d078ecb6a3 TARGET-30-PANZRV TARGET-30-PANZRV-01A-01R 1 72 1 3434 0 Censored Alive 3434 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma Low Risk 0 0 230d1eae-b3b6-4db5-9fc0-7446ee92b717 TARGET-30-PANUKV TARGET-30-PANUKV-01A-01R 1 1486 2 356 1 Relapse Dead 404 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 250ed70c-1090-459e-b17e-c6420e1c39de TARGET-30-PALVKK TARGET-30-PALVKK-01A-01R 2 1810 2 217 1 Event Dead 1033 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 95/5 271dabcc-3b9e-4ebd-9a93-ca2ee6b9d863 TARGET-30-PANSBN TARGET-30-PANSBN-01A-01R 1 2329 2 505 1 Relapse Dead 836 1 4 Not Amplified 0 Unfavorable 1 Differentiating High 3 "Ganglioneuroblastoma, nodular" High Risk 1 0 279b261e-3ec4-44da-8d70-879ce84a79ab TARGET-30-PASMDM TARGET-30-PASMDM-01A-01R 1 25 1 1324 0 Censored Alive 1324 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Low Risk 0 40/60 301b4e88-545d-4c7e-9422-7faa968942fd TARGET-30-PAPTCR TARGET-30-PAPTCR-01A-01R 2 754 2 394 1 Event Dead 456 1 4 Unknown NA Unknown NA Unknown Unknown NA Neuroblastoma High Risk 1 20/80 626adafd-e4a3-477b-8ad3-48ed04d4d95c TARGET-30-PASUYG TARGET-30-PASUYG-01A-01R 1 1418 2 505 1 Relapse Alive 2193 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 60/40 640a9338-f476-4c71-a6a0-52d8f618f6dc TARGET-30-PAPBZI TARGET-30-PAPBZI-01A-01R 1 1710 2 172 1 Progression Dead 430 1 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA Neuroblastoma High Risk 1 0 671c70da-e21e-4dd6-bcbd-6ed30fb78278 TARGET-30-PAPKWN TARGET-30-PAPKWN-01A-01R 2 710 2 260 1 Relapse Dead 465 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 0 692a3229-af33-4136-bc6e-a4b22f016cde TARGET-30-PALBFW TARGET-30-PALBFW-01A-01R 1 804 2 611 1 Relapse Dead 1073 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 80/20 739f5018-d0d0-4f8c-9a70-f2e2aad9d466 TARGET-30-PARVLK TARGET-30-PARVLK-01A-01R 2 6021 2 428 1 Event Dead 875 1 4 Not Amplified 0 Unknown NA Unknown Unknown NA "Ganglioneuroblastoma, intermixed" High Risk 1 70/30 753eb36e-4e92-49ed-b563-5e0b8635b30c TARGET-30-PAPUAR TARGET-30-PAPUAR-01A-01R 2 515 1 3065 0 Censored Alive 3065 0 4 Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 70/30 773e8883-2d4c-4bbf-8176-f8acdfeb3368 TARGET-30-PASXIE TARGET-30-PASXIE-01A-01R 1 837 2 2123 0 Censored Alive 2123 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 30-40/60-70 0828a945-a123-4166-b93e-2071bd743c71 TARGET-30-PAMNLH TARGET-30-PAMNLH-01A-01R 2 1531 2 361 1 Relapse Dead 837 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 "Ganglioneuroblastoma, nodular" High Risk 1 0 0851d235-5d5f-48d2-9e39-3e8a8863b5bb TARGET-30-PAPBJE TARGET-30-PAPBJE-01A-01R 1 1860 2 3467 0 Censored Alive 3467 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 0 887df144-5092-434f-bb48-cc0ab0ab77ec TARGET-30-PASWYR TARGET-30-PASWYR-01A-01R 1 958 2 1893 0 Censored Alive 1893 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 60/40 2145ebc8-5ed7-4a70-bf17-0198874e2ffe TARGET-30-PALUYS TARGET-30-PALUYS-01A-01R 2 1214 2 693 1 Relapse Dead 1284 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 40/60 4116d3d5-c025-4e2f-a675-cfb71c8351ed TARGET-30-PAKZRH TARGET-30-PAKZRH-01A-01R 1 21 1 3341 0 Censored Alive 3341 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Unknown Intermediate Risk 0 0 4194ec92-38f7-4449-b698-95da75eae017 TARGET-30-PAPTLV TARGET-30-PAPTLV-01A-01R 2 641 2 366 1 Relapse Dead 575 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 0 4803fc06-e2de-44aa-b76e-f8fe9308c18d TARGET-30-PARAMT TARGET-30-PARAMT-01A-01R 1 885 2 493 1 Death Dead 493 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 "Ganglioneuroblastoma, nodular" High Risk 1 80/20 6508e923-51d3-41a3-9fe4-dbe7a7fe7139 TARGET-30-PATESI TARGET-30-PATESI-01A-01R 1 752 2 622 1 Relapse Dead 958 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 75/25 6790b6ce-1be7-420a-b08b-1d9ce8fad4a3 TARGET-30-PARGKK TARGET-30-PARGKK-01A-01R 1 2241 2 1075 1 Progression Dead 1321 1 4 Not Amplified 0 Unfavorable 1 Differentiating Low 1 Neuroblastoma High Risk 1 40/60 6892ab76-6690-4da1-83a7-c9ce5e19eb22 TARGET-30-PASUCB TARGET-30-PASUCB-01A-01R 1 1008 2 1976 0 Censored Alive 1976 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 90/10 7029a8f0-0bbe-4db1-9254-2517c87adba6 TARGET-30-PATEKG TARGET-30-PATEKG-01A-01R 2 1275 2 1988 0 Censored Alive 1988 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 "Ganglioneuroblastoma, nodular" High Risk 1 90/10 19709a7e-d7ae-45db-a8e6-5424c08e6dd6 TARGET-30-PASWVY TARGET-30-PASWVY-01A-01R 2 2477 2 1918 0 Censored Alive 1918 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 "Ganglioneuroblastoma, nodular" High Risk 1 60/40 32616b41-5681-4f62-ac75-b40f935c9c7b TARGET-30-PALCBW TARGET-30-PALCBW-01A-01R 2 679 2 4565 0 Censored Alive 4565 0 4 Not Amplified 0 Favorable 0 Differentiating Low 1 Neuroblastoma High Risk 1 0 86234da9-2f20-47a3-a2b6-44800328bdcf TARGET-30-PANNMS TARGET-30-PANNMS-01A-01R 2 1080 2 3509 0 Censored Alive 3509 0 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA Neuroblastoma High Risk 1 0 86804d13-b05b-4c23-8e83-653fc4212de7 TARGET-30-PASPBZ TARGET-30-PASPBZ-01A-01R 1 62 1 2347 0 Censored Alive 2347 0 4s Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma Intermediate Risk 0 0 305357aa-30a7-458f-a023-ede757d64591 TARGET-30-PAPUEB TARGET-30-PAPUEB-01A-01R 2 1595 2 2772 0 Censored Alive 2772 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Unknown NA Neuroblastoma High Risk 1 40/60 391324ba-9289-4a11-854d-1602da0094d1 TARGET-30-PAPVRN TARGET-30-PAPVRN-01A-01R 1 2300 2 2889 0 Censored Alive 2889 0 4 Not Amplified 0 Unfavorable 1 Differentiating Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 0 733557c7-a67c-4e2e-92cc-a9b29d4eca3f TARGET-30-PASNPG TARGET-30-PASNPG-01A-01R 2 318 1 302 1 Event Alive 2274 0 3 Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma Intermediate Risk 0 90/10 925151ab-0679-43a4-808f-2e4237cfd7fc TARGET-30-PARFWB TARGET-30-PARFWB-01A-01R 1 1555 2 1105 1 Relapse Dead 1836 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 90/10 2546775a-bcc8-4983-ae23-f03491e3a27d TARGET-30-PARBGP TARGET-30-PARBGP-01A-01R 2 3625 2 1524 1 Relapse Dead 2039 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 70-80/20-30 2961321f-a06c-4ead-9bfd-b27d99e4ef08 TARGET-30-PATEPF TARGET-30-PATEPF-01A-01R 1 1434 2 304 1 Death Dead 304 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 "Ganglioneuroblastoma, nodular" High Risk 1 90/10 4638324b-b8e5-4545-8b7b-e8d7d7fdd138 TARGET-30-PATYIL TARGET-30-PATYIL-01A-01R 2 328 1 239 1 Relapse Dead 481 1 4 Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma Intermediate Risk 0 70/30 9704403e-aaf9-4a97-99bc-b2a9a9861767 TARGET-30-PAITCI TARGET-30-PAITCI-01A-01R 1 728 2 232 1 Event Dead 324 1 4 Not Amplified 0 Favorable 0 Differentiating Low 1 Neuroblastoma High Risk 1 90/10 44643665-e3b2-4d0d-990b-c1ef6c50b00b TARGET-30-PAPTAN TARGET-30-PAPTAN-01A-01R 1 1462 2 2054 0 Censored Alive 2054 0 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA "Ganglioneuroblastoma, nodular" High Risk 1 40/60 76263959-d77a-47d4-aed5-66ded04d0b9e TARGET-30-PARKGJ TARGET-30-PARKGJ-01A-01R 1 1616 2 841 1 Relapse Dead 1636 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 80/20 a0c20437-5cbd-47f2-a635-9466a8d61c25 TARGET-30-PALETP TARGET-30-PALETP-01A-01R 2 1466 2 251 1 Death Dead 251 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 a3bf1ee6-d71c-43ee-b775-6d28176bb8a9 TARGET-30-PATCFL TARGET-30-PATCFL-01A-01R 1 1041 2 2125 0 Censored Alive 2125 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 20-30/80-70 ac395ca9-205e-45fd-89c1-d7676306e624 TARGET-30-PARACS TARGET-30-PARACS-01A-01R 1 1180 2 1328 0 Censored Alive 1328 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 80/20 ace0c57d-c209-4e59-a8d7-c26cf72bce1a TARGET-30-PATAYJ TARGET-30-PATAYJ-01A-01R 1 52 1 1744 0 Censored Alive 1744 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Low Risk 0 0 ae90fe2e-b857-463a-be07-b4ad9babc334 TARGET-30-PANBMJ TARGET-30-PANBMJ-01A-01R 1 993 2 577 1 Relapse Dead 3776 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 0 aeb9f3e0-28f9-4126-b276-0f787d19ef36 TARGET-30-PAMVRA TARGET-30-PAMVRA-01A-01R 2 1554 2 2433 1 Death Dead 2433 1 4 Not Amplified 0 Unfavorable 1 Differentiating Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 0 af82838c-9071-4dd7-8766-b818cf61cf82 TARGET-30-PAIFXV TARGET-30-PAIFXV-01A-01R 2 2004 2 630 1 Event Dead 1114 1 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA Unknown High Risk 1 0 afa10943-b0b6-49f9-8706-6ee5da9c6454 TARGET-30-PAPZYZ TARGET-30-PAPZYZ-01A-01R 2 550 2 1209 0 Censored Alive 1209 0 4 Amplified 1 Unknown NA Unknown Unknown NA Neuroblastoma High Risk 1 60/40 afd2b4fc-a690-4716-9c94-5769cd117089 TARGET-30-PASYPX TARGET-30-PASYPX-01A-01R 2 1514 2 296 1 Progression Alive 2215 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 afdcbe2a-e23f-43de-9bae-ed6e146333dd TARGET-30-PAMMXF TARGET-30-PAMMXF-01A-01R 1 1661 2 140 1 Relapse Dead 197 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 90/10 b1d954e7-21a0-441e-a9c7-47e6a6454625 TARGET-30-PAIPGU TARGET-30-PAIPGU-01A-01R 2 898 2 436 1 Death Dead 436 1 4 Not Amplified 0 Unknown NA Unknown Unknown NA Unknown High Risk 1 95/5 b2b0bec1-334c-4b94-a9d8-81206911dd42 TARGET-30-PANBSP TARGET-30-PANBSP-01A-01R 2 1064 2 470 1 Relapse Dead 659 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 0 b7fd0fc8-a27d-46d6-a782-d5b624aa81fe TARGET-30-PASWFB TARGET-30-PASWFB-01A-01R 2 727 2 87 1 Death Dead 87 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 90/10 b62a4938-b6e7-4b5b-8033-9ae0d0893afd TARGET-30-PARDIW TARGET-30-PARDIW-01A-01R 1 2048 2 2829 0 Censored Alive 2829 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 10/90 b1623fd7-b407-4a82-910d-c0e57518e608 TARGET-30-PASPER TARGET-30-PASPER-01A-01R 2 753 2 638 1 Progression Alive 2087 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 90/10 b9987cb1-394a-4ab3-96b9-e06bbcd6e31e TARGET-30-PARDCK TARGET-30-PARDCK-01A-01R 2 2060 2 2991 0 Censored Alive 2991 0 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA "Ganglioneuroblastoma, nodular" High Risk 1 90/10 b1893955-2d73-4d1f-967a-22664fbd494b TARGET-30-PAPUWY TARGET-30-PAPUWY-01A-01R 2 1955 2 765 1 Relapse Dead 1102 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 40/60 bbb067bf-d4ae-46be-8bea-3f71d371b7f8 TARGET-30-PASGAP TARGET-30-PASGAP-01A-01R 1 1330 2 1285 1 Progression Dead 1543 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 90/10 bfa13bce-0369-4315-8c94-903b898dbcaf TARGET-30-PASWIJ TARGET-30-PASWIJ-01A-01R 1 2537 2 1940 0 Censored Alive 1940 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 80/20 c2be6c07-fb29-4f17-8c3a-6327f4ec3235 TARGET-30-PARNNC TARGET-30-PARNNC-01A-01R 2 41 1 735 1 Relapse Alive 2611 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Low Risk 0 10-20/80-90 c7fae254-b4aa-4d2d-abd1-8c96da54a00e TARGET-30-PANRRW TARGET-30-PANRRW-01A-01R 1 1730 2 408 1 Relapse Alive 2178 0 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA Neuroblastoma High Risk 1 0 c863478e-1746-43f1-8e1e-d87e0cc101ef TARGET-30-PAPVFD TARGET-30-PAPVFD-01A-01R 1 1961 2 1765 1 Death Dead 1765 1 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA Neuroblastoma High Risk 1 90/10 cd0c500a-90eb-4981-85b9-8688cfb7876f TARGET-30-PANYGR TARGET-30-PANYGR-01A-01R 1 993 2 281 1 Progression Dead 283 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Unknown NA Neuroblastoma High Risk 1 0 d3b3a2f3-d18f-494f-92b7-db15a14ccec4 TARGET-30-PASXRG TARGET-30-PASXRG-01A-01R 2 1278 2 1749 0 Censored Alive 1749 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 "Ganglioneuroblastoma, nodular" High Risk 1 70-80/20-30 d7fefb38-3c90-4b7d-9d9e-85e1ca18eb3f TARGET-30-PARZHA TARGET-30-PARZHA-01A-01R 1 3 1 2489 0 Censored Alive 2489 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Low Risk 0 0 d8d30bd7-608d-4cbd-ba31-3f1fa6fefacf TARGET-30-PAIVHE TARGET-30-PAIVHE-01A-01R 1 1123 2 672 1 Event Dead 1605 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 70/30 d8d936d7-5483-48ab-90af-c5e5fa675d9b TARGET-30-PATGLU TARGET-30-PATGLU-01A-01R 1 1037 2 715 1 Relapse Dead 1330 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 80/20 d9a69f61-4a4e-4eb3-90f5-e486c646e006 TARGET-30-PAMZMG TARGET-30-PAMZMG-01A-01R 2 614 2 533 1 Relapse Dead 763 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 d12b7288-10b2-41fc-b5c0-b6227d5b92af TARGET-30-PANGXK TARGET-30-PANGXK-01A-01R 1 1266 2 1855 1 Event Alive 3792 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 "Ganglioneuroblastoma, nodular" High Risk 1 95/5 d40bb6fb-fb99-4907-8d19-f0469f10bd10 TARGET-30-PASNEF TARGET-30-PASNEF-01A-01R 2 696 2 2213 0 Censored Alive 2213 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 85/15 d153c7a0-df42-4e61-81b9-2e72467c0ed7 TARGET-30-PASSWW TARGET-30-PASSWW-01A-01R 1 7 1 2095 0 Censored Alive 2095 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Intermediate Risk 0 90/10 ddfcc35e-fdce-400c-93cf-f4c62e7d22c7 TARGET-30-PAMEZH TARGET-30-PAMEZH-01A-01R 2 746 2 330 1 Death Dead 330 1 4 Amplified 1 Unknown NA Unknown Unknown NA Unknown High Risk 1 75/25 df7a35a0-dc6a-4801-a962-be2e171eb773 TARGET-30-PAUDDK TARGET-30-PAUDDK-01A-01R 1 361 1 344 1 Event Alive 1528 0 3 Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma Intermediate Risk 0 0 e3eabcbe-d0e8-42a2-8533-2abbfcb84b20 TARGET-30-PAPLSD TARGET-30-PAPLSD-01A-01R 1 710 2 583 1 Relapse Dead 1383 1 4 Not Amplified 0 Unknown NA Unknown Unknown NA Neuroblastoma High Risk 1 20/80 e6e480c6-9af2-4afe-8b30-d869c635fdb7 TARGET-30-PASSRN TARGET-30-PASSRN-01A-01R 1 5345 2 2227 0 Censored Alive 2227 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 35/65 e21dce4f-7e4e-44e7-8e38-4353d59125e6 TARGET-30-PATDWN TARGET-30-PATDWN-01A-01R 1 1435 2 278 0 Censored Alive 278 0 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 70/30 e99cf13e-9bdf-402d-9ec4-a8bf771543a5 TARGET-30-PARHAM TARGET-30-PARHAM-01A-01R 2 341 1 38 1 Progression Dead 2466 1 4 Not Amplified 0 Favorable 0 Unknown Unknown NA Neuroblastoma Intermediate Risk 0 90/10 e2471e44-3677-40cd-9768-a71301fa2e53 TARGET-30-PASFGG TARGET-30-PASFGG-01A-01R 2 1037 2 700 1 Death Dead 700 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 60/40 e4220b7a-96e1-468b-9911-b1bf54ca0c09 TARGET-30-PANZVU TARGET-30-PANZVU-01A-01R 1 1713 2 934 1 Death Dead 934 1 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA Neuroblastoma High Risk 1 0 e516732d-caf8-40f4-aa2a-2d250c7ce5b1 TARGET-30-PASMJG TARGET-30-PASMJG-01A-01R 2 1765 2 1162 1 Progression Dead 1544 1 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Unknown NA "Ganglioneuroblastoma, nodular" High Risk 1 90/10 ec63aa87-9456-416b-9f74-a2b25e80b2c2 TARGET-30-PARJVP TARGET-30-PARJVP-01A-01R 1 56 1 2064 0 Censored Alive 2064 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Unknown NA Neuroblastoma Low Risk 0 90/10 ec70002f-5275-4abb-9054-c1e9b105fda3 TARGET-30-PALXTB TARGET-30-PALXTB-01A-01R 1 635 2 4621 0 Censored Alive 4621 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 0 ed5045df-3b18-41b8-ad62-a5a598ee3889 TARGET-30-PAKYZS TARGET-30-PAKYZS-01A-01R 1 659 2 238 1 Progression Alive 3587 0 4 Not Amplified 0 Unknown NA Unknown Unknown NA Unknown High Risk 1 0 f3d1dd95-37da-48be-88f2-0312bdc161d2 TARGET-30-PAPCTS TARGET-30-PAPCTS-01A-01R 1 2008 2 2236 1 Relapse Dead 2636 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Unknown NA Neuroblastoma High Risk 1 0 f9c9806d-716e-405d-babf-1f2142b449df TARGET-30-PANUIF TARGET-30-PANUIF-01A-01R 2 2234 2 3726 0 Censored Alive 3726 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 0 f9ea6862-a705-4bd5-af11-16a683364b25 TARGET-30-PAPICY TARGET-30-PAPICY-01A-01R 2 58 1 205 0 Censored Alive 205 0 4s Not Amplified 0 Favorable 0 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma Low Risk 0 0 f99e2b20-96d7-49f3-bdd2-7a1cf2fa6208 TARGET-30-PASNZU TARGET-30-PASNZU-01A-01R 1 1099 2 954 1 Relapse Dead 1692 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated High 3 Neuroblastoma High Risk 1 90/10 f7541bf7-73bc-4163-af01-3fea29027a16 TARGET-30-PAPHPE TARGET-30-PAPHPE-01A-01R 1 806 2 453 1 Relapse Dead 470 1 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA Neuroblastoma High Risk 1 98/2 f510617c-68c6-4c99-b50b-589242906d1b TARGET-30-PANLET TARGET-30-PANLET-01A-01R 2 1973 2 830 1 Relapse Dead 1212 1 4 Not Amplified 0 Unfavorable 1 Unknown Unknown NA "Ganglioneuroblastoma, nodular" High Risk 1 0 fa2e0b15-1ed1-462c-991f-2e279493dba1 TARGET-30-PANJLH TARGET-30-PANJLH-01A-01R 1 1010 2 500 1 Death Dead 500 1 4 Amplified 1 Unfavorable 1 Undifferentiated or Poorly Differentiated Intermediate 2 Neuroblastoma High Risk 1 0 fab58ae3-1afd-40eb-a7e3-fd6236840671 TARGET-30-PANKFE TARGET-30-PANKFE-01A-01R 2 1280 2 402 0 Censored Alive 402 0 4 Not Amplified 0 Unfavorable 1 Undifferentiated or Poorly Differentiated Low 1 Neuroblastoma High Risk 1 90/10